Pharmaceutical Export to Asia
Asia represents one of the most diverse pharmaceutical markets globally, spanning highly regulated markets like Japan and Singapore through to rapidly developing healthcare systems across South and Southeast Asia. The Indian Pharma exports WHO-GMP compliant medicines to hospitals, distributors, importers, and government procurement programs across the continent, with product availability confirmed per country based on local registration status.
Countries We Export To Across Asia
South Asia
Bangladesh, Bhutan, Nepal, Sri Lanka, Maldives, Pakistan, Afghanistan
Southeast Asia
Vietnam, Philippines, Myanmar, Cambodia, Thailand, Malaysia, Singapore, Indonesia, Laos, Brunei, Timor-Leste
East Asia
China, Japan, South Korea, North Korea, Mongolia, Taiwan, Hong Kong, Macau
Central Asia
Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan
Products in Highest Demand
| Category | Coverage |
|---|---|
| Oncology & immunotherapy biologics | Rising cancer treatment demand across the region |
| Rare disease medicines | Named-patient supply where local registration is limited |
| Anti-infectives | High regional infectious disease burden |
| Generic essential medicines | Public health system bulk procurement |
Why Asian Buyers Source from India
| Factor | Detail |
|---|---|
| Geographic proximity | Shorter transit times, faster delivery |
| Cost advantage | Competitive pricing vs. Western-sourced alternatives |
| Regulatory familiarity | Many Asian regulators recognize WHO-GMP standards |
| Cold chain reliability | GDP-compliant logistics for biologics |
FAQs
Which countries in Asia do you currently export to?
Our active corridors span South Asia (Bangladesh, Nepal, Sri Lanka, and others), Southeast Asia (Vietnam, Philippines, Thailand, and more), and additional markets in East and Central Asia — availability is confirmed per country based on product registration status.
Do you support government tenders in Southeast Asia?
Yes, we provide tender-compliant pricing and documentation for government health department procurement across the region.
Can hospitals in Asia source oncology biologics directly?
Yes, hospitals can source directly with full cold-chain logistics and documentation support.
Is named-patient import supported for rare disease medicines?
Yes, for countries where a specific medicine isn't yet locally registered, we support the named-patient and compassionate-use import pathway.
What documentation is required for import into Asian markets?
Requirements vary by country, but typically include Certificate of Analysis, Certificate of Origin, and WHO-GMP certification — we confirm the exact requirement for your destination before shipment.
